Rush Clinical Trial Provides New Kidney Cancer Immunotherapy …Clinical LeaderRush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney …and more »… Continue reading
Nature.comStem cells The different flavours of iPS cellsNature.comThe use of induced pluripotent stem (iPS) cells for studying genetic variants that underlie human diseases is complicated by the fact that individual iPS cell lines are genetically and p… Continue reading
Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell …Dove Medical PressAbstract: Clinical trials and studies have shown that combination estrogen/progestin hormone replacement therapy, bu… Continue reading
Rush clinical trial offers new immunotherapy combination to patients fighting kidney cancerNews-Medical.netRush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced ki… Continue reading
Rush clinical trial offers new immunotherapy combination to patients …News-Medical.netRush University Medical Center is among the first hospitals in the nation, and the only one in Illinois, to provide patients fighting advanced kidney access to a&nb… Continue reading
Christian News Network |
Burn Victims Restored by Adult Stem Cell Technology
Christian News Network (Christian Institute) — Burn victims may no longer be forced to undergo painful skin grafts, thanks to a revolutionary piece of technology that uses adult stem cells. Instead of taking skin from one part of the body and transplanting it onto the … |
Christian News Network |
Burn Victims Restored by Adult Stem Cell Technology
Christian News Network (Christian Institute) — Burn victims may no longer be forced to undergo painful skin grafts, thanks to a revolutionary piece of technology that uses adult stem cells. Instead of taking skin from one part of the body and transplanting it onto the … |
Nature.com |
T cells get a ride
Nature.com Direct activation of LTβR with an agonistic antibody — CBE11 — in combination with anti-angiogenic immunotherapy enhanced HEV formation, the immune response, apoptosis and necrosis in RT2-PNET, MMTV-PyMT and GBM models. Together, these … |